Moreover, targeting GPX4 using RSL3 in GSTZ1-knockout and SR HCC cells significantly increased iron accumulation, ROS level, and lipid peroxidation production and enhanced sorafenib-induced inhibition of cell proliferation. This evidence concerns the gene GSTZ1 and hepatocellular carcinoma.